CAS 27062-01-7: Naphth[2,3-b]oxiren-2(1aH)-one,4,5,6,6a,7,7a-hexahydro-7-(1-hydroxy-1-methylethyl)-6,6a-dimethyl-,(1aS,6R,6aR,7S,7aS)-

Isonardosinone, a nardosinone-type sesquiterpene from Nardostachys jatamansi, exhibits anti-neuroinflammatory and cytotoxic activities.

Isonardosinone is a synthetic compound, which is derived from a laboratory-based chemical process designed to mimic naturally occurring neuroactive substances. It functions primarily as a neuromodulator, acting on specific neurotransmitter pathways within the central nervous system. By interacting with receptor sites, it can influence synaptic transmission, potentially modulating neurological activity. In terms of applications, Isonardosinone is under investigation for its role in neuroprotection and the management of neurodegenerative disorders. Its ability to modulate neurotransmitter systems may offer therapeutic benefits in conditions characterized by neuronal damage and neurotransmitter imbalance. Current research is exploring its efficacy and safety profiles in various experimental models, aiming to better understand its potential for clinical use. Given its mechanism of action, Isonardosinone could represent a novel approach in addressing conditions such as Alzheimer's disease, Parkinson's disease, and other cognitive impairments, though more research is required to fully elucidate its clinical potential.